Cited by 112Cancer-related Molecular PathwaysDevelopmental Biology and Gene RegulationPI3K/AKT/mTOR signaling in cancer

p53 ancestry: gazing through an evolutionary lens

Lu, Wan-Jin, Amatruda, James F., Abrams, John M.·2009·Nature reviews. Cancer

Abstract

Evolutionary patterns indicate that primordial p53 genes predated the appearance of cancer. Therefore, wild-type tumour suppressive functions and mutant oncogenic functions that give celebrity status to this gene family were probably co-opted from unrelated primordial activities. Is it possible to deduce what these early functions might have been? And might this knowledge provide a platform for therapeutic opportunities?

Integrity signals

Registry

Crossref · 10.1038/nrc2732

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • p53 may take part in other essential physiological processes, such as stem cell homeostasis and fertility.

    “There is increasing evidence that in addition to the ‘classical’ function of p53 in the DNA damage response, this versatile protein might be involved in other essential physiological processes, including stem cell homeostasis and fertility [106–108].”

    From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [108]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lu, W.-J., Amatruda, J. F., & Abrams, J. M.
Affiliations
The University of Texas Southwestern Medical Center (US)
Corresponding author
Abrams, John M.
Venue
Nature reviews. Cancer
Published
2009-10
Volume
9
Issue
10
Pages
758-762
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
OpenAlex
W1991091416
Cited by
112
References
58
Citations by year
2024: 1 · 2023: 10 · 2022: 5 · 2021: 2 · 2020: 7 · 2019: 8 · 2018: 9 · 2017: 9 · 2016: 16 · 2015: 6 · 2014: 7 · 2013: 9 · 2012: 5
FWCI
0.67
Type
journal article
Language
en
Open access
closed
Locations
  • Nature reviews. Cancer (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Alcohol Abuse and Alcoholism
  • National Institute of General Medical Sciences (R56GM072124)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
p53, tumor suppressor, tumor evolution, cancer therapy
MeSH terms
Animals, Humans, Genes, p53, Tumor Suppressor Protein p53, Evolution, Molecular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review